ARIX — Arix Bioscience Share News
0.000.00%
Last trade - 00:00
- £183.80m
- £82.85m
- £0.11m
- 29
- 34
- 90
- 48
REG-Arix Bioscience PLC Portfolio Company Disc Medicine Completes Merger with Gemini Therapeutics
AnnouncementREG-Arix Bioscience PLC Unaudited NAV for November 2022
AnnouncementREG-Arix Bioscience PLC Arix to Present at Mello Investment Trusts & Funds
AnnouncementREG - Arix Bioscience Plc - Director/PDMR Shareholding
AnnouncementREG-Arix Bioscience PLC Unaudited NAV for October 2022
AnnouncementREG-Arix Bioscience PLC Director/PDMR Shareholding
AnnouncementREG-Arix Bioscience PLC Holding(s) in Company
AnnouncementREG-Arix Bioscience PLC Portfolio Company Imara Announces Merger Agreement with Enliven Therapeutics
AnnouncementREG-Arix Bioscience PLC Unaudited NAV for September 2022
AnnouncementREG-Arix Bioscience PLC Director/PDMR Shareholding
AnnouncementREG-Arix Bioscience PLC Arix Portfolio Company Aura Biosciences Presents Interim Phase 2 Data Highlighting Belzupacap Sarotalocan (AU-011) Suprachoroidal Efficacy and Safety at AAO 2022
AnnouncementREG-Arix Bioscience PLC Unaudited NAV for August 2022
AnnouncementREG-Arix Bioscience PLC Unaudited NAV for July 2022
AnnouncementREG-Arix Bioscience PLC Artios initiates Phase 2 study of Polθ Inhibitor ART4215 in Combination with PARP Inhibitor Talazoparib in BRCA Deficient Breast Cancer
AnnouncementREG-Arix Bioscience PLC Portfolio Company Disc Medicine Enters Definitive Merger Agreement with Gemini Therapeutics
AnnouncementREG-Arix Bioscience PLC Interim Results for the Six Months Ended 30 June 2022
AnnouncementREG-Arix Bioscience PLC Arix Bioscience plc Announces Changes to Board of Directors
AnnouncementREG-Arix Bioscience PLC Notice of Results & Investor Presentation
AnnouncementREG-Arix Bioscience PLC Unaudited NAV for June 2022
Announcement